Doctors Hospital at Renaissance, Cancer Center at Renaissance, and the Renaissance Cancer Foundation have partnered together to present the 6th Annual “Por Su Vida” event in association with La Salud Del Valle

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

 EDINBURG, TX— Breast Cancer continues to be the most common cancer among women worldwide and the second most common cancer overall. In 2014, an estimated 232,030 cases of invasive breast cancer will be diagnosed in the U.S. However, it is important to know that at this present time a breast cancer diagnosis is not a death sentence, and it can be treated.

For that reason, we want to celebrate the breast cancer survivors in our community with a fashion show and dinner event, where the survivors will get to support one another and commemorate the triumph of their battling cancer. The event will be held on Wednesday, October 29, 2014 at the Edinburg Conference Center at Renaissance 6:00 PM to 8:00 PM. 

“Por Su Vida” will feature actual breast cancer survivors modeling clothing sponsored by Dillard’s at La Plaza Mall. Speakers such as medical oncologist Eugenio Galindo, M.D. will remind attendees about the importance of continuing breast examinations and spreading the word on cancer awareness to all their friends and family. As our special entertainment number, Rhythm Room Dance Studio will perform several dance numbers for our audience. The event will also offer breast cancer awareness information and a Dillard’s fashion show.  Many door prizes and giveaways will also be donated to our guests.

- Advertisement -

We look forward for you to join us and thank you for your continued support. 

 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.
- Advertisement -